Silencing cytokine-inducible SH2 (CIS) containing protein in NK cells increases production levels of IFN-γ and TNF-α, enhancing cancer cells apoptosis mediated by allogeneic NK cells and improving overall survival in mice with GBM [323]. The gene discussed is IFNG; the disease is glioblastoma.